Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

for
Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: Female

Age: 0+

Code: NCT04781725

Phase 2, Recruiting

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for
Locally Advanced or Metastatic Malignant Solid Tumors
Location: New Hyde Park NY, Hackensack NJ, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07287995

Phase 1, Phase 2, Recruiting

Tumor Related Epilepsy

for
Epilepsy, Cancer, Brain Neoplasm
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 8 - 70+

Code: NCT02639325

Recruiting

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

for
Neoplasms
Location: Grand Rapids MI, Chicago IL, San Antonio TX,
Sponsor: Corcept Therapeutics

Sex: All

Age: 18+

Code: NCT07276373

Phase 1, Phase 2, Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

for
Melanoma, Metastatic Melanoma, Advanced Solid Tumor,
Location: La Jolla CA
Sponsor: Replimune Inc.

Sex: All

Age: 18+

Code: NCT06887348

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

for
Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer,
Location: Orlando FL, Nashville TN, Houston TX
Sponsor: Phrontline Biopharma

Sex: All

Age: 18+

Code: NCT07181473

Phase 1, Recruiting

DPTX3186 in Wnt Pathway Activated Solid Tumors

for
Solid Tumors
Location: Boston TN, New Haven CT, New York NY, Fairfax VA,
Sponsor: Dewpoint Therapeutics

Sex: All

Age: 18+

Code: NCT07312903

Phase 1, Recruiting

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05746325

Recruiting

Impact of Physician Behavior on Cancer Distress

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07325006

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07223047

Phase 1, Phase 2, Recruiting

A Study of YL242 in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New Haven CT, Sarasota FL, Grand Rapids MI,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07197827

Phase 1, Phase 2, Recruiting

BostonGene-Integrated Genomic Registry (BIGR)

for
Malignancy
Location: Waltham MA
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT04991922

Recruiting

Emotion and Symptom-Focused Engagement (EASE) for Caregivers

for
Trauma and Stressor Related Disorders, Pediatric Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06367556

Recruiting

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

for
Metastatic Cancer, Oligoprogressive
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04989725

Phase 2, Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

for
Invasive Ductal Breast Carcinoma,
Location: Commack NY, Norwalk CT, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 45+

Code: NCT04084730

Phase 2, Recruiting

STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study

for
Advanced Solid Tumor, Metastatic Cancer
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT07269080

Phase 1, Recruiting

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise

for
Breast Cancer, Metastatic Breast Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07313306

Recruiting

Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer

for
Cancer, Adolescents
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 10 - 25

Code: NCT07220343

Recruiting

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

for
Patients Undergoing Routine Health Care, Heart Diseases,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT01280825

Recruiting

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Lake Mary FL, Louisville KY, Denver CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial